Immunotherapies and other cancer treatments don’t work well on “cold” tumors, also known as immunological deserts, because they usually have few T cells.
One of the novel synthesis’s key features is a bioinspired photooxygenation-allylic hydroperoxide rearrangement sequence that makes it easier to add functional groups in the synthesis’s final stages.
A recent study sheds light on why leukaemic stem cells that were spared from chemotherapy go on to proliferate and develop into AML cells after treatment.
